from AXA (EPA:CS)
AXA - Elimination of the dilutive impact of Shareplan 2026
Press release
Paris, October 1, 2026
Elimination of the dilutive impact of Shareplan 2026
In the context of the AXA Group’s 2026 employee share offering (Shareplan 2026)1 and in order to eliminate any associated dilutive effect, AXA has executed today a share repurchase agreement with an investment services provider, whereby AXA will buy back its own shares for cancellation for a maximum amount of Euro 470,800,000 in accordance with the terms of its share repurchase program2.
The price per share to be paid by AXA shall be determined on the basis of the arithmetic average of the daily volume-weighted average AXA share prices calculated over a period of 20 trading days commencing on October 2, 2026 and corresponding to the fixing period for the shares to be issued under Shareplan 20263.
Share buyback transactions by the investment services provider conducted in relation to this agreement will not extend beyond October 29, 2026.
ABOUT THE AXA GROUP
The AXA Group is a worldwide leader in insurance, with 156,000 employees serving more than 92 million clients in 52 countries. In 2025, revenues amounted to Euro 115.5 billion and underlying earnings to Euro 8.4 billion.
The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000102628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA’s American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY.
The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.
It is a founding member of the UN Environment Programme’s Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.
This press release and the regulated information made public by AXA pursuant to article L. 451-1-2 of the French Monetary and Financial Code and articles 222-1 et seq. of the Autorité des marchés financiers’ General Regulation are available on the AXA Group website (axa.com).
THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE axa.com
FOR MORE INFORMATION:
Investor Relations: +33.1.40.75.48.42
investor.relations@axa.com
Individual Shareholder Relations: +33.1.40.75.48.43
Media Relations: +33.1.40.75.46.74
ziad.gebran@axa.com
ahlem.girard@axa.com
sylwia.tulak@axa.com
Corporate Responsibility strategy:
axa.com/en/commitments/responsible-business
SRI ratings:
axa.com/en/investor/sri-ratings-ethical-indexes
IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS
Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans, expectations or objectives, and other information that is not historical information. Forward-looking statements are generally identified by words and expressions such as “expects”, “anticipates”, “may”, “plan” or any variations or similar terminology of these words and expressions, or conditional verbs such as, without limitations, “would” and “could”. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties, many of which are outside AXA’s control, and can be affected by other factors that could cause AXA’s actual results to differ materially from those expressed in, or implied or projected by, such forward-looking statements. Each forward-looking statement speaks only at the date of this press release. Please refer to Chapter 5 - “Risk factors and Risk Management” of AXA’s Universal Registration Document for the year ended December 31, 2025, for a description of certain important factors, risks and uncertainties that may affect AXA’s business and/or results of operations. AXA specifically disclaims and undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise, except as required by applicable laws and regulations.
Notes
- The AXA Group’s 2026 employee share offering (Shareplan 2026) has been authorized by the General Shareholders’ Meeting of April 30, 2026. Please refer to the press release issued on September 9, 2026 for further information on Shareplan 2026.
- The AXA share repurchase program has been authorized by the General Shareholders’ Meeting of April 30, 2026.
- The purchase price will not exceed the maximum purchase price approved at the General Shareholders’ Meeting of April 30, 2026.